Ana Boban and Flora Peyvandi
Feb 17, 2026, 14:32
Flora Peyvandi: Population Pharmacokinetics to Guide Tailored Surgical Dosing in Von Willebrand Disease
Flora Peyvandi, Professor of Internal Medicine – Hemostasis and Thrombosis Unit at University of Milan, shared a post on X about a recent article by Ana Boban published in Blood Advances:
“Population PK of aVWF: toward personalized surgery”
Title: Population PK of VWF: toward personalized surgery
Author: Ana Boban
Read the Full Article on Blood Advances.
Find more posts featuring Flora Peyvandi on Hemostasis Today.
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE